Mawallafi: Gregory Harris
Ranar Halitta: 9 Afrilu 2021
Sabuntawa: 19 Nuwamba 2024
Anonim
Hydatidiform tawadar Allah - Magani
Hydatidiform tawadar Allah - Magani

Hydatidiform mole (HM) wani abu ne mai girma ko girma wanda ke samuwa a cikin mahaifar (mahaifa) a farkon ciki. Nau'in cututtukan ciki ne na gland (GTD).

HM, ko ciki mai ciki, yana haifar da haɗuwar mahaifa daga oocyte (ƙwai). Yana haifar da tayi mara kyau. Maziyyi yana girma daidai yadda ya kamata tare da rashin ci gaban kayan tayi. Naman mahaifa yana samar da abu mai yawa a mahaifa. A kan duban dan tayi, wannan yawancin yana da kamannin inabi, saboda yana dauke da kananan cysts dayawa.

Samun damuwar kwayar halitta ya fi girma a cikin tsofaffin mata. Tarihin kwayar halitta a cikin shekarun baya shima yana da matsala.

Cutar ciki na miji na iya zama iri biyu:

  • Ciki mai ciki na ciki: Akwai mahaifa mara kyau da kuma ci gaban tayi.
  • Cikakken ciki mai ciki: Akwai mahaifa mara kyau kuma babu tayi.

Babu wata hanyar da zata hana samuwar wadannan mutane.

Kwayar cututtukan ciki na miji na iya haɗawa da:

  • Ciwan mahaifa na al'ada, ko dai girma ko ƙanƙantar da yadda aka saba
  • Tsananin jiri da amai
  • Jinin azzakari na azzakarin cikin wata 3 na farko na ciki
  • Kwayar cututtukan hyperthyroidism, gami da rashin haƙuri da zafi, kujerun mara kwance, saurin bugun zuciya, rashin nutsuwa ko damuwa, fata mai dumi da danshi, hannuwan da ke rawar jiki, ko kuma rashin nauyi wanda ba a bayyana ba
  • Kwayar cututtukan da suka yi kama da preeclampsia da ke faruwa a farkon watanninsu na farko ko farkon farkon watanni na biyu, gami da hawan jini da kumburi a ƙafa, ƙafafun kafa, da ƙafafu (wannan kusan kusan wata alama ce ta kwayar halittar hydatidiform, saboda cutar preeclampsia ba safai ake samun sa ba a farkon wannan ciki na al'ada)

Mai ba ku kiwon lafiya zai yi gwajin ƙashin ƙugu, wanda na iya nuna alamun kama da ciki na al'ada. Koyaya, girman mahaifar na iya zama mahaukaci kuma bazai sami sautin zuciya daga jaririn ba. Hakanan, ana iya samun zubar jini na farji.


Tsarin duban dan tayi zai nuna yanayin dusar kankara tare da mahaifa mara kyau, tare da ko ba tare da samun ci gaban jariri ba.

Gwaje-gwajen da aka yi na iya haɗawa da:

  • hCG (matakan adadi) gwajin jini
  • Ciki ko duban duban dan tayi
  • Kirjin x-ray
  • CT ko MRI na ciki (gwajin hoto)
  • Kammala ƙididdigar jini (CBC)
  • Gwajin jini
  • Gwajin koda da hanta

Idan mai ba ka sabis ya yi tsammanin ɗaukar ciki, za a iya ba da shawarar cire abin da ba shi da kyau tare da faɗaɗawa da warkarwa (D&C). Hakanan ana iya yin D&C ta amfani da tsotsa. Wannan shi ake kira fata tsotsa (Hanyar tana amfani da kofin tsotsa don cire abin da ke ciki daga mahaifar).

Wani lokaci ciki mai ɗan ɗanowa na iya ci gaba. Mace na iya zaɓar ci gaba da ɗaukar ciki da fatan samun nasarar haihuwa da haihuwa. Koyaya, waɗannan suna da haɗarin haɗari sosai. Haɗarin na iya haɗawa da zub da jini, matsaloli game da hawan jini, da kuma saurin kawowa (haihuwa da jariri kafin ya zama cikakke). A cikin al'amuran da ba safai ba, ɗan tayi na al'ada ne. Mata suna buƙatar tattauna abubuwan haɗari gaba ɗaya tare da mai ba su kafin ci gaba da ɗaukar ciki.


Hysterectomy (tiyata don cire mahaifa) na iya zama zaɓi ga tsofaffin mata waɗanda BA sa son yin ciki a nan gaba.

Bayan magani, za'a bi matakin hCG naka. Yana da mahimmanci a guji wani juna biyu kuma a yi amfani da amintaccen maganin hana daukar ciki na tsawon watanni 6 zuwa 12 bayan an yi jiyya don daukar ciki. Wannan lokacin yana ba da izini don cikakken gwaji don tabbatar cewa ƙwayar mahaukaci ba ta girma ba. Matan da suke samun juna biyu nan bada jimawa ba bayan sun sami juna biyu na cikin hadari na sake samun juna biyu.

Yawancin HMs ba su da matsala (marasa kyau). Jiyya yawanci ana samun nasara. Kusa da kulawa daga mai ba da sabis yana da mahimmanci don tabbatar da cewa alamun ciki na ɓacin rai sun tafi kuma matakan hormone na ciki ya dawo na al'ada.

Kimanin kashi 15% na shari'o'in HM na iya zama ɓarna. Wadannan moles na iya girma cikin zurfin bangon mahaifa kuma suna haifar da zub da jini ko wasu matsaloli. Wannan nau'in kwayar halitta galibi tana amsawa da kyau ga magunguna.

A cikin 'yan ƙananan halaye na cikakke HM, ƙwayoyin cuta suna haɓaka cikin choriocarcinoma. Wannan ciwon daji ne mai saurin girma. Yawancin lokaci ana samun nasarar magance shi tare da chemotherapy, amma yana iya zama barazanar rai.


Matsalolin ciki mara wuya na iya haɗawa da:

  • Canja zuwa cututtukan ƙwayoyin cuta ko choriocarcinoma
  • Preeclampsia
  • Matsalar thyroid
  • Cutar ciki da ke ci gaba ko dawowa

Rikitarwa daga tiyata don cire ciki mai ciki na iya haɗawa da:

  • Zub da jini mai yawa, mai yiwuwa ana buƙatar ƙarin jini
  • Sakamakon sakamako na maganin sa barci

Kwayoyin Hydatid; Cutar ciki; Hyperemesis - molar

  • Mahaifa
  • Anatwararren ƙwayar mahaifa na al'ada (yanki)

Bouchard-Fortier G, Alkawari A. Cutar cututtukan ciki na gestational: hydatidiform mole, nonmetastatic da metast gestational glandation trophoblastic tumor: ganewar asali da gudanarwa. A cikin: Lobo RA, Gershenson DM, Lentz GM, Valea FA, eds. M Gynecology. 7th ed. Philadelphia, PA: Elsevier; 2017: babi na 35.

Goldstein DP, Berkowitz RS. Cutar cututtukan ciki na ciki. A cikin: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff na Clinical Oncology. 5th ed. Philadelphia, PA: Elsevier Saunders; 2014: babi na 90.

Salani R, Copeland LJ. Mummunan cututtuka da ciki. A cikin: Gabbe SG, Niebyl JR, Simpson JL, et al, eds. Obetetrics: Ciki da Ciki. 7th ed. Philadelphia, PA: Elsevier; 2017: babi na 50.

Salhi BA, Nagrani S. Babban rikitarwa na ciki. A cikin: Walls RM, Hockberger RS, Gausche-Hill M, eds. Magungunan gaggawa na Rosen: Ka'idoji da Aikin Gwajin Asibiti. 9th ed. Philadelphia, PA: Elsevier; 2018: babi na 178.

Shahararrun Posts

Gwajin fata na Lepromin

Gwajin fata na Lepromin

Ana amfani da gwajin fatar kuturta don tantance irin kuturta da mutum yake da ita.Wani amfurin inactivated (wanda baya iya haifar da kamuwa da cuta) kwayoyin cutar kuturta ana allurar u a ƙarƙa hin fa...
Abemaciclib

Abemaciclib

[An buga 09/13/2019]Ma u auraro: Mai haƙuri, Ma anin Kiwon Lafiya, OncologyMa 'ala: FDA tana gargadin cewa palbociclib (Ibrance®), ribociclib (Ki qali®), da abemaciclib (Verzenio®) wanda ake amfan...